Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q1 2024 · 10-Q
Revenue$22.68M$22.68M+15.3% vs Q1 2023 Net Income-$1.73M-$1.73MN/M vs Q1 2023 EPS Diluted-$0.06-$0.06N/M vs Q1 2023 Gross Profit$3,064,000+17.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flow-$2,380,000N/M Free Cash Flowderived-$2,519,000— Margins · derivedGross margin13.5%+0.3 pt vs Q1 2023
Operating margin-5.8%+1.4 pt vs Q1 2023
Net margin-7.6%+1.3 pt vs Q1 2023
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end